Updated: January 3, 2026
Alternatives to Molnupiravir If You Can't Fill Your Prescription
Author
Peter Daggett

Summarize with AI
- Why Was Molnupiravir Prescribed Instead of Paxlovid?
- Alternative #1: Paxlovid (Nirmatrelvir/Ritonavir)
- Alternative #2: Remdesivir (Veklury)
- Alternative #3: Supportive Care (When No Antiviral Is Available)
- Which Alternative Is Right for You?
- Try medfinder First — You May Not Need an Alternative
- Bottom Line
Can't find molnupiravir (Lagevrio) in stock? Here are the best alternatives for COVID-19 treatment and when to consider them in 2026.
You were prescribed molnupiravir (Lagevrio) for COVID-19, but your pharmacy doesn't have it — and neither do the next three you called. Now the clock is ticking on your 5-day treatment window. What do you do?
The good news is that there are FDA-authorized and approved alternatives to molnupiravir for COVID-19. The right option depends on your health situation, other medications you take, and what's accessible near you. Here's what you and your doctor need to know.
Why Was Molnupiravir Prescribed Instead of Paxlovid?
Before discussing alternatives, it's important to understand why you were given molnupiravir in the first place. Molnupiravir (Lagevrio) is typically the third-line COVID-19 treatment, recommended only when Paxlovid and remdesivir are not accessible or appropriate. The most common reason: Paxlovid interacts with many medications, especially blood thinners, statins, immunosuppressants, and seizure medications. If your drug regimen made Paxlovid too risky, your provider likely chose molnupiravir because it has no known drug-drug interactions.
When considering alternatives, your provider will weigh those same factors. Share your full medication list before switching.
Alternative #1: Paxlovid (Nirmatrelvir/Ritonavir)
Paxlovid is the FDA-approved first-line oral COVID-19 antiviral for high-risk adults. Studies show it is more effective than molnupiravir at clearing the virus — one direct comparison found viral clearance was 84% faster with Paxlovid than without treatment, vs. 37% faster with molnupiravir. If your prescriber originally avoided Paxlovid due to drug interactions, they may be able to temporarily pause or adjust the interacting medication to allow Paxlovid — a process called "drug holiday." This is a clinical decision only your provider can make.
Key differences from molnupiravir:
Full FDA approval (not just EUA)
More effective at reducing hospitalizations and deaths
Major drug interactions with ritonavir component (dozens of common medications)
Can be prescribed by pharmacists directly in many states (not available for Lagevrio)
Also taken as 3 tablets twice daily for 5 days — oral and convenient
Alternative #2: Remdesivir (Veklury)
Remdesivir (Veklury), made by Gilead Sciences, is an IV antiviral that is the second-line recommended treatment for COVID-19. For outpatients, it's given as three consecutive daily infusions (Days 1, 2, and 3) at an infusion center or hospital outpatient facility. While less convenient than a pill, remdesivir has no drug-drug interactions with most medications and is an option for patients who can't take oral antivirals.
Key considerations:
Requires three clinic or hospital visits over 3 consecutive days
Not practical for patients with mobility limitations or no transportation
Fully FDA approved for COVID-19 in adults and children
Studies show similar mortality outcomes to molnupiravir in systematic reviews
Alternative #3: Supportive Care (When No Antiviral Is Available)
If no antiviral is accessible within your treatment window and your doctor cannot pivot to another option, supportive care becomes the priority. This means:
Rest, hydration, and fever management
Monitoring oxygen levels at home with a pulse oximeter
Calling your doctor if symptoms worsen significantly
Going to the emergency room if you experience difficulty breathing, persistent chest pain, or confusion
Which Alternative Is Right for You?
Only your healthcare provider can determine the safest and most effective alternative for your situation. Here's a quick overview to guide that conversation:
If drug interactions were the barrier to Paxlovid: Ask your provider if a temporary "drug holiday" is possible.
If you can get to a clinic for 3 consecutive days: Ask about IV remdesivir.
If you're pregnant: Discuss all options with your OB — molnupiravir is not recommended in pregnancy either.
Try medfinder First — You May Not Need an Alternative
Before giving up on molnupiravir, make sure you've searched thoroughly. medfinder is a paid service that calls pharmacies near you to check real-time availability. Many patients who "can't find" their medication haven't searched far enough — medfinder expands that search automatically and texts you the results.
Read our full guide on how to find molnupiravir in stock near you before switching medications.
Bottom Line
If you truly cannot find molnupiravir in time, Paxlovid (with drug interaction management) and IV remdesivir are the most effective alternatives. Contact your prescriber immediately — don't wait until the treatment window has closed to have this conversation.
Frequently Asked Questions
According to NIH guidelines, Paxlovid (nirmatrelvir/ritonavir) is the preferred first-line COVID-19 antiviral for high-risk adults. Remdesivir (Veklury) is the second-line option. Molnupiravir is third-line, typically used only when Paxlovid and remdesivir are inaccessible or inappropriate. If you cannot find molnupiravir, ask your provider about switching to Paxlovid or getting IV remdesivir.
This is a clinical decision only your provider can make. In general, you should not switch antiviral medications mid-course without medical guidance. Contact your prescriber right away if you are having trouble filling molnupiravir.
Remdesivir (Veklury) is the second-line recommended COVID-19 treatment and may be effective. However, it requires IV infusions at a clinic for 3 consecutive days, which is less convenient than an oral pill. It is a strong alternative for patients who cannot take either oral antiviral.
Direct head-to-head studies show that Paxlovid clears the COVID-19 virus more quickly — one study found viral clearance was 84% faster with Paxlovid vs. 37% faster with molnupiravir. For most high-risk patients who can safely take it, Paxlovid is the more effective option. Molnupiravir's key advantage is having no known drug interactions.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Molnupiravir also looked for:
More about Molnupiravir
29,818 have already found their meds with Medfinder.
Start your search today.





